Substance,Type of TRV,TRV Value,Study Details,"Threshold/
Non-threshold
Endpoint",TRV Derivation Method,"Critical
Effect(s)","Carcinogenicity
Classification",Source
"Dichloroethylene,
1,1","Oral TDI
(referred to as
an ‘acceptable
daily intake’
in HC, 1994)","3.0E-03
mg/kg -day
BW","Study Type: chronic
Species: Sprague-Dawley rats
Mode of Administration: oral
(drinking water)
Exposure Regime: time weighted
average daily doses: 0, 7, 10, and
20 mg/kg -day (males); 0, 9, 14, and
BW
30 mg/kg -day (females)
BW
Duration: 2 years
Uncertainty Factors: 3000 (10 for
intraspecies variability, 10 for interspecies
variability, 10 for use of a LOAEL, and
3 for limited evidence of carcinogenicity)","LOAEL =
9 mg/kg -day
BW",TDI = LOAEL/UF,"Hepatoxicity
(hepatocellular
swelling with
mid-zonal fatty
changes)","CEPA:
not assessed
IARC: Group 3
not classifiable as to
its carcinogenicity
to humans
(IARC, 1999a)
US EPA IRIS:
inhalation route:
suggestive
evidence of
carcinogenicity,
but not sufficient
to assess human
carcinogenic
potential;
oral route:
inadequate data
for assessment of
human carcinogenic
potential
(US EPA, 2002)","HC, 1994
(based on
Quast et al.,
1983)"
"Dichloromethane
(methylene
chloride)",Oral TDI,"1.4E-02
mg/kg -day
BW","Study Type: chronic
Species: male and female F344 rats
Mode of Administration: oral
(drinking water)
Exposure Regime: 0, 5, 50, 125, and
250 mg/kg -day; additional group
BW
at 250 mg/kg -day
BW
Duration: 104 weeks; additional group
was exposed for 78 weeks + 26 week
recovery period
Uncertainty Factors: 300 (10 for
intraspecies variability, 10 for
interspecies variability, and 3 for
database deficiencies)","BMDL =
10
4.2 mg/kg -day
BW","TDI = BMDL /UF
10","Hepatotoxicity
(increased
incidences of
foci and areas of
cellular alterations
in liver)","CEPA: Group II
probably
carcinogenic
to humans
(EC and HC, 1993e)
IARC: Group 2A
probably
carcinogenic
to humans
(IARC, 2017)
US EPA IRIS:
carcinogenic
by a mutagenic
mode of action
(US EPA, 2011a)","HC, 2011a
(based on
Serota et al.,
1986a)"
